ArticleBlood2013

Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry.

Martin Höglund et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.